These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33836878)

  • 1. Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell-Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia.
    Shelikhova L; Glushkova S; Nikolaev R; Dunaikina M; Zhekhovtsova Z; Blagov S; Khismatullina R; Balashov D; Kurnikova E; Pershin D; Muzalevskii Y; Kazachenok A; Osipova E; Trakhtman P; Maschan A; Maschan M
    Transplant Cell Ther; 2021 Apr; 27(4):330.e1-330.e9. PubMed ID: 33836878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of αβ T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia.
    Dunaikina M; Zhekhovtsova Z; Shelikhova L; Glushkova S; Nikolaev R; Blagov S; Khismatullina R; Balashov D; Kurnikova E; Pershin D; Muzalevskii Y; Kazachenok A; Osipova E; Miakova N; Litvinov D; Novichkova G; Maschan A; Maschan M
    Bone Marrow Transplant; 2021 Jul; 56(7):1614-1624. PubMed ID: 33594278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical Cord Blood Transplantation with 8 mg/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg/kg Antithymocyte Globulin in the Treatment of Acute Leukemia.
    Yuan F; Li G; Li M; Wei X; Fu Y
    Transplant Cell Ther; 2023 Dec; 29(12):771.e1-771.e10. PubMed ID: 37748539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.
    Glushkova S; Shelikhova L; Voronin K; Pershin D; Vedmedskaya V; Muzalevskii Y; Kazachenok A; Kurnikova E; Radygina S; Ilushina M; Khismatullina R; Maschan A; Maschan M
    Transplant Cell Ther; 2024 Apr; 30(4):435.e1-435.e12. PubMed ID: 38278183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-Based Antithymocyte Globulin in αβhaplo-Hematopoietic Stem Cell Transplantation Facilitates Engraftment, Expedites T Cell Recovery, and Mitigates the Risk of Acute Graft-versus-Host Disease.
    Barbarito G; Hiroshima L; Oppizzi L; Saini G; Kristovich K; Klein O; Hosszu K; Boehlke K; Gupta A; Mcavoy D; Shyr D; Boelens JJ; Bertaina A
    Transplant Cell Ther; 2024 Aug; 30(8):810.e1-810.e16. PubMed ID: 38768907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patients.
    Pan M; Wu Y; Yang L; Zhu P; Shi J; Lai X; Liu L; Zhao Y; Yu J; Huang H; Luo Y
    Ann Hematol; 2024 Aug; 103(8):3105-3119. PubMed ID: 38829409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
    Shelikhova L; Ilushina M; Shekhovtsova Z; Shasheleva D; Khismatullina R; Kurnikova E; Pershin D; Balashov D; Radygina S; Trakhtman P; Kalinina I; Muzalevskii Y; Kazachenok A; Zaharova V; Brilliantova V; Olshanskaya Y; Panferova A; Zerkalenkova E; Baidildina D; Novichkova G; Rumyantsev A; Maschan A; Maschan M
    Biol Blood Marrow Transplant; 2019 May; 25(5):e179-e182. PubMed ID: 30677509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
    Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
    [No Abstract]   [Full Text] [Related]  

  • 9. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial.
    Naik S; Li Y; Talleur AC; Selukar S; Ashcraft E; Cheng C; Madden RM; Mamcarz E; Qudeimat A; Sharma A; Srinivasan A; Suliman AY; Epperly R; Obeng EA; Velasquez MP; Langfitt D; Schell S; Métais JY; Arnold PY; Hijano DR; Maron G; Merchant TE; Akel S; Leung W; Gottschalk S; Triplett BM
    J Hematol Oncol; 2024 Jun; 17(1):50. PubMed ID: 38937803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
    Duléry R; Bastos J; Paviglianiti A; Malard F; Brissot E; Battipaglia G; Médiavilla C; Giannotti F; Banet A; de Wyngaert ZV; Ledraa T; Belhocine R; Sestili S; Adaeva R; Lapusan S; Isnard F; Legrand O; Vekhoff A; Rubio MT; Ruggeri A; Mohty M
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1407-1415. PubMed ID: 30871978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation.
    Clausen J; Böhm A; Straßl I; Stiefel O; Buxhofer-Ausch V; Machherndl-Spandl S; König J; Schmidt S; Steitzer H; Danzer M; Kasparu H; Weltermann A; Nachbaur D
    Biomedicines; 2017 Mar; 5(2):. PubMed ID: 28536356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients.
    Wang Y; Wu DP; Liu QF; Xu LP; Liu KY; Zhang XH; Yu WJ; Xu Y; Huang F; Huang XJ
    J Hematol Oncol; 2019 Sep; 12(1):88. PubMed ID: 31481121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.
    Jacoby E; Varda-Bloom N; Goldstein G; Hutt D; Churi C; Vernitsky H; Toren A; Bielorai B
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3
    Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
    Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant.
    Wu H; Shi J; Luo Y; Yu J; Lai X; Liu L; Fu H; Ouyang G; Xu X; Xiao H; Huang H; Zhao Y
    JAMA Netw Open; 2022 Apr; 5(4):e226114. PubMed ID: 35385089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.
    Locatelli F; Merli P; Pagliara D; Li Pira G; Falco M; Pende D; Rondelli R; Lucarelli B; Brescia LP; Masetti R; Milano GM; Bertaina V; Algeri M; Pinto RM; Strocchio L; Meazza R; Grapulin L; Handgretinger R; Moretta A; Bertaina A; Moretta L
    Blood; 2017 Aug; 130(5):677-685. PubMed ID: 28588018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating Factor.
    Tang FF; Cheng YF; Xu LP; Zhang XH; Yan CH; Han W; Chen YH; Huang XJ; Wang Y
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1655-1662. PubMed ID: 32504861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.